About this trial
CAPTURE ALS is a long-term data and biorepository platform that will facilitate future ALS research. CAPTURE ALS will provide the standardized systems and tools necessary to collect, store, and analyze vast amounts of multimodal information about ALS. These multimodal datasets and biosamples will be made available for use by researchers or industry across Canada and around the world in accordance with the CAPTURE ALS Data Sharing Policy to advance research on ALS.
Eligibility criteria
Qualifiers
Has ALS, classified as definite, probable, laboratory-supported probable, or possible ALS according to the revised El Escorial criteria or a related neurodegenerative disorder including ALS-FTD, PLS, PMA or asymptomatic individuals with a known ALS mutation (as previously confirmed during regular clinical care)
Be of the age of majority in their province of residence/treatment
Have the cognitive capacity to provide informed consent
Have proficiency in English or French in order to understand study instructions and respond to questionnaires
Disqualifiers
Be between the ages of 40-80 unless age matched to a patient (+/-3 years) who is already enrolled
Be the age of majority in their province of residence/treatment
Have the cognitive capacity to provide informed consent
Have proficiency in English of French to understand study instructions and respond to questionnaires
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
University of Alberta
Lead sponsor
McGill University
Collaborator
Laval University
Collaborator
University of Toronto
Collaborator
Simon Fraser University
Collaborator